JUL 12, 2016 7:30 AM PDT

Introduction to the PATHFAST, a Cardiac Biomarker Analyzer Specializing in Precise and Accurate Results Unaffected by Hemolysis

Sponsored by: Vert Clinical Leader
Speakers

Abstract:

PATHFAST is a small, benchtop cardiac marker analyzer with industry-leading precision designed for ED and stat labs. PATHFAST is the only point-of-care cardiac biomarker analyzer in the market with a 5.1% CV for Troponin I at the 99th percentile cutoff. With the flexibility to run whole blood or plasma samples, PATHFAST allows for up to six simultaneous tests in under 17 minutes. The test menu includes Troponin, CK-MB, NTproBNP, D-Dimer, hsCRP and Myoglobin, and test results are unaffected by hemolysis, providing accurate, fast results – helping clinicians diagnose patients more effectively and efficiently.
 
Our goal is to not just to provide the best whole blood cardiac biomarker analyzer in the industry, but to improve the quality of patient care while simultaneously reducing costs.
 
PATHFAST is manufactured in Japan, from quality components, and under the strictest quality control standards.
 


Show Resources
You May Also Like
OCT 02, 2019 11:00 AM PDT
OCT 02, 2019 11:00 AM PDT
DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
SEP 05, 2019 4:00 PM CEST
C.E. CREDITS
SEP 05, 2019 4:00 PM CEST
DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
FEB 26, 2020 9:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
FEB 26, 2020 9:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
OCT 22, 2019 9:00 AM PDT
C.E. CREDITS
OCT 22, 2019 9:00 AM PDT
DATE: October 22, 2019 TIME: 9:00am PDT, 12:00PM EDT...
SEP 19, 2019 9:00 AM PDT
C.E. CREDITS
SEP 19, 2019 9:00 AM PDT
DATE: September 19, 2019TIME: 9:00am PT, 12:00pm ET Cancer research continues to push the boundaries with new advancements in tissue analysis and biomarker detection. Now, more...
AUG 27, 2019 9:00 AM PDT
C.E. CREDITS
AUG 27, 2019 9:00 AM PDT
DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
Loading Comments...
Show Resources